Overactive Bladder Syndrome Clinical Trial
Official title:
Effect of Telerehabilitation on Overactive Bladder Symptoms and Metabolic Health in Obese Women
Overactive bladder syndrome(OAB) is a chronic medical condition which has a major influence on the quality of life in a significant amount of the population. The goal of this clinical trial study to identify the effect of telerehabilitation program on overactive bladder symptoms and metabolic health in obese women and to compare between the telerehabilitation group and the control group regarding overactive bladder symptoms and metabolic health in obese women.
Status | Recruiting |
Enrollment | 80 |
Est. completion date | December 30, 2023 |
Est. primary completion date | December 15, 2023 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 35 Years to 45 Years |
Eligibility | Inclusion Criteria: - women aged 35-45 years old - class I obesity(30-34.9kg/m2) - women will be referred by urologist with Presence of overactive bladder symptoms confirmed by overactive bladder questionnaire - waist circumference more than 88 cm Exclusion Criteria: - history of surgical treatment of urological disease - infection of urinary tract - oncological and neurological urinary tract disease, - refusal to participate in the study |
Country | Name | City | State |
---|---|---|---|
Egypt | Online Video Programs With Patients Referred From Urologist ( Kasr Eleiny Hospital) | Giza |
Lead Sponsor | Collaborator |
---|---|
Cairo University |
Egypt,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | body mass index | it is calculated by dividing weight in kg on height in m square | at baseline and after 12 weeks of the intervention | |
Primary | waist circumference | it is an indicator of central obesity with waist circumference more than 88 cm is considered central obesity in females | at baseline and after 12 weeks of the intervention | |
Primary | overactive bladder questionnaire short form | is a questionnaire that is divided into two sections : symptoms and quality of life. In symptoms section, the higher the scores the more the symptoms that bother the patients. higher scores in quality of life section indicates better quality of life. | at baseline and after 12 weeks of the intervention | |
Primary | patient perception of intensity of urgency scale | a scale ranges from 0 to 4 that measures the degree of urgency with micturition with higher scores indicate higher perception of urgency | at baseline and after 12 weeks of the intervention | |
Primary | HOMA IR | The homeostatic model assessment (HOMA IR) is a method used to quantify insulin resistance . derived from the product of the insulin and glucose values divided by a constant. | at baseline and after 12 weeks of the intervention | |
Secondary | telehealth usability questionnaire | a comprehensive questionnaire that covers all usability factors (i.e., usefulness, ease of use, effectiveness, reliability, and satisfaction). It is used with various types of telehealth systems, including the traditional videoconferencing systems, computer-based systems, and the mobile telehealth systems. | after 12 weeks of the intervention |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02540707 -
Comparisons of the Effects of Solifenacin Versus Mirabegron on Autonomic System, Arterial Stiffness and Psychosomatic Distress and Clinical Outcomes
|
Phase 4 | |
Not yet recruiting |
NCT05977634 -
Transcutaneous Tibial Nerve Stimulation for Idiopathic Overactive Bladder
|
N/A | |
Not yet recruiting |
NCT06438861 -
Role of Combination Therapy in Women With Refractory Overactive Bladder
|
N/A | |
Completed |
NCT01114412 -
Basic Sensations Coming From the Bladder
|
||
Recruiting |
NCT03952299 -
Oxybutynin for Post-surgical Bladder Pain and Urgency
|
Phase 3 | |
Active, not recruiting |
NCT03758235 -
Overactive Bladder Syndrome: Incobotulinumtoxin Versus Onabotulinumtoxin
|
Phase 3 | |
Completed |
NCT01912885 -
Comparison of Posterior Tibial Nerve Electrical Stimulation Protocols for Overactive Bladder Syndrome
|
N/A | |
Completed |
NCT04300400 -
Treatment of the Overactive Bladder Syndrome: A Delphi Study
|
||
Recruiting |
NCT04982120 -
Use of Repris Needle in Bladder Injection
|
N/A | |
Completed |
NCT06123364 -
Extracorporeal Magnetic Innervation in Combination With Mirabegron in the Treatment of Overactive Bladder
|
N/A | |
Recruiting |
NCT06088394 -
Effect of Acupuncture Augmented With Pelvic Floor Exercises on Overactive Bladder
|
N/A | |
Recruiting |
NCT05221021 -
Vaginal Estradiol vs Oral Beta-3 Agonist for Overactive Bladder Syndrome
|
Phase 4 | |
Terminated |
NCT04256876 -
TTNS Versus Sham Therapy for Children With iOAB (TaPaS Part I)
|
N/A | |
Not yet recruiting |
NCT03331081 -
Effects of Bladder Training and Pelvic Floor Muscle Training on the Symptomatology of Overactive Bladder Syndrome
|
N/A | |
Recruiting |
NCT04873037 -
BTL Emsella Chair Versus Sham for the Treatment of Overactive Bladder
|
N/A | |
Completed |
NCT02024945 -
Efficacy, Tolerability and Impact on Quality of Life of Propiverine in Patients With Overactive Bladder Syndrome
|
Phase 4 | |
Completed |
NCT00546637 -
Fesoterodine "add-on" Male Overactive Bladder Study
|
Phase 3 | |
Not yet recruiting |
NCT06143397 -
Effect of TTNS and PNS on Neurogenic Overactive Bladder Symptoms in Female Patients With Multiple Sclerosis.
|
N/A | |
Recruiting |
NCT03044912 -
Therapeutic Efficacy and Safety of Mirabegron Treatment on Patients With Overactive Bladder Syndrome in Taiwan
|
Phase 3 | |
Recruiting |
NCT03817203 -
Effects of Kinesio Taping Application in Women With Overactive Bladder
|
N/A |